![](https://s3-eu-west-1.amazonaws.com/newscentre/news-content/C859A_635880890761893515_11JAN2016.jpg)
An American gene sequencing company is working towards a universal blood test to identify early-stage cancers in people with no symptoms of the disease. San Diego-based Illumina Inc. is forming a new company, called Grail, with more than AED 350 million of finance. Microsoft’s Bill Gates and Jeff Bezos, founder of Amazon.com are two of the high profile investors.